Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05919771 · ClinicalTrials.gov registry record

Effects of Rock Climbing on Parkinson's Disease

A clinical trial, sponsored by Marymount University.

Completed
Registry status
32
Enrollment target

NCT05919771 is a clinical trial that has completed, run by Marymount University. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05919771 has completed, sponsored by Marymount University.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking \& mobility, hand strength \& dexterity, and psychological well-being in individuals with Parkinson's Disease (PD). The rock climbing sessions are administered and supervised by Up ENDing Parkinson's, and are tailored to the skill level of the participant. Participants will answer questionnaires and complete physical performance tests twice, first prior to beginning the sessions and then again after the 24 sessions have been completed.

Interventions

  • OTHER rock climbing

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-07-12
Est. Completion 2024-08-12

Sponsor

Marymount University

6 total trials

What the Registry Record Tells You About NCT05919771

The ClinicalTrials.gov registry entry for NCT05919771 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marymount University, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which rock climbing is the first listed.

NCT05919771 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05919771 about?

NCT05919771 is a clinical study titled "Effects of Rock Climbing on Parkinson's Disease". This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking \& mobility, hand strength \& dexterity, and psychological well-being in individuals with Parkinson's D...

What is the current status of trial NCT05919771?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2023-07-12. Estimated completion is 2024-08-12.

What interventions are being tested in trial NCT05919771?

The interventions under investigation include: rock climbing (OTHER).

Who is sponsoring clinical trial NCT05919771?

This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.